DI-077 Use of romiplostim in patients with idiopathic thrombocytopenic purpura

@article{Walsh2015DI077UO,
  title={DI-077 Use of romiplostim in patients with idiopathic thrombocytopenic purpura},
  author={A Valladolid Walsh and N Jimenez Collados and M Clemente And{\'u}jar and C Garc{\'i}a G{\'o}mez and G Romero Candel and Sergio Plata Paniagua and N Monteagudo Mart{\'i}nez},
  journal={European Journal of Hospital Pharmacy-Science and Practice},
  year={2015},
  volume={22}
}
Background Romiplostim was approved in 2009 to treat adult splenectomised patients with chronic Idiopathic Thrombocytopenic Purpura (ITP) when refractory to other treatment. It is also considered second-line treatment in non-splenectomised patients in which surgery is not advised. Purpose To determine the effectiveness and safety of romiplostim in patients with ITP who did not respond to 1st line or later treatments. Material and methods Observational and retrospective study. All patients… 
An Idiopathic Thrombocytopenic Purpura Patient Treated With Homeopathy: A Case Report
TLDR
This case showed that homeopathic medicine can be a treatment modality for idiopathic thrombocytopenic purpura (ITP), an autoimmune-mediated hematologic disorder.